Mr. NianWang | Machine Learning | Best Researcher Award

Posted on by sciencefather

Mr. NianWang | Machine Learning | Best Researcher Award šŸ†

Xiā€™an Research Institute of High-tech, Xi ‘an, Shaanxi, ChinašŸŽ“

Nian Wang is a dedicated PhD candidate at the Xiā€™an Research Institute of High-tech in Xiā€™an, China. Specializing in machine learning and deep learning applications, Nian has established himself as a promising researcher, with extensive experience as a journal reviewer for prominent IEEE publications.

 

Professional ProfileĀ 

  • google scholar

Education šŸŽ“:

Nian Wang is currently pursuing a PhD at the Xiā€™an Research Institute of High-tech, specializing in advanced machine learning techniques.

Work Experience šŸ’¼:

As a PhD candidate, Nian is actively engaged in cutting-edge research and has gained valuable experience through serving as a reviewer for prominent journals such as IEEE Transactions on Image Processing and Pattern Recognition.

 

Skills šŸ”:

Nian possesses expertise in deep learning, data clustering, image enhancement, and object recognition. His skills in developing innovative solutions for complex image processing problems have been demonstrated through his research contributions.

Awards and Honors šŸ†:

In 2022, Nian received the Excellent Doctoral Dissertation award from the China Ordnance Industry Society, recognizing his significant academic contributions.

Memberships šŸ¤:

Currently, Nian holds no formal memberships in professional organizations, focusing primarily on his research and academic contributions.

Teaching Experience šŸ‘©ā€šŸ«:

While there are no formal teaching roles mentioned, his involvement in research and peer review indicates a strong understanding of academic concepts, which can translate into potential future teaching opportunities.

Research Focus šŸ”¬:

Nianā€™s research is centered on machine learning applications, particularly in data clustering, image dehazing, and UAV object tracking. His innovative work includes developing the Capsule Attention Network (CAN) for hyperspectral image classification, showcasing improved performance and reduced computational burden compared to existing methods.

ConclusionĀ 

In conclusion, Nian Wang is a highly suitable candidate for the Best Researcher Award due to his innovative contributions, recognized expertise, and commitment to advancing research in machine learning. His achievements speak volumes about his potential for future advancements in the field. By addressing areas for improvement, Nian can enhance his profile further, positioning himself as a leader in research and innovation. Awarding him this honor would not only recognize his past accomplishments but also encourage his continued contributions to the scientific community.

šŸ“š PublilcationĀ 

 

Prof. Clement Furlong | biochemistry | Best Researcher Award

Posted on by sciencefather

Prof. Clement Furlong | biochemistry | Best Researcher Award šŸ†

Professor, Depts. Medicine & Genome Sciences at Ā University of Washington,United StatesšŸŽ“

Clement E. Furlong, PhD, a distinguished researcher in the fields of biochemistry and molecular biology, has made significant contributions through his extensive education and experience. With a Ph.D. from the University of California, Davis, and postdoctoral training at Cornell University, Dr. Furlong has held several prominent positions at the University of Washington, shaping the landscape of medical genetics and toxicology. His research primarily focuses on paraoxonases, their role in neurotoxicity, and their implications for public health, particularly in relation to environmental exposures.

Professional ProfileĀ 

šŸŽ“ Education

Dr. Clement E. Furlong obtained his B.A. in Chemistry from San Jose State College in 1963, followed by a Ph.D. in Biochemistry from the University of California, Davis, in 1968. He completed a PHS Postdoctoral Fellowship in Biochemistry and Molecular Biology at Cornell University from 1968 to 1970 and underwent sabbatical training in immunology at Stanford University from 1976 to 1977.

šŸ¢ Work Experience

Dr. Furlong began his academic career as an Assistant Professor of Biochemistry at the University of California, Riverside (1970-1975), advancing to Associate Professor before transitioning to the University of Washington, where he held several prominent positions including Research Associate Professor, Research Professor, and currently serves as a Professor of Medicine in the Division of Medical Genetics and Genome Sciences since 2011. He also holds an Adjunct Professor role in the Department of Environmental and Occupational Health Sciences and is a Research Affiliate at the UW Center on Human Development and Disability.

šŸ§¬ Skills

Dr. Furlong is highly skilled in biochemistry, molecular biology, and toxicology, with a focus on paraoxonases and their role in neurotoxicity. His extensive background in research, mentorship, and training equips him to guide students and colleagues effectively.

Awards and Honors šŸ†

Throughout his career, Dr. Furlong has received numerous accolades, including B.A. Honors in Chemistry, memberships in Sigma Xi, and multiple U.S. Public Health Service fellowships. He was awarded the Paper of the Year Award from the Journal of Human and Ecological Risk Assessment in 2002.

MembershipsšŸ“œĀ 

Dr. Furlong is an active member of professional organizations such as the Society of Toxicology and Sigma Xi, contributing to the advancement of research in toxicology and biochemistry.

šŸ“š Teaching Experience

As a dedicated educator, Dr. Furlong has taught courses in Genome Sciences and Environmental Health. He has mentored numerous undergraduate and graduate students, guiding them through their research projects and thesis work.

šŸ”¬ Research Focus

Dr. Furlongā€™s research primarily centers on the biochemical and molecular mechanisms of environmental exposure and its effects on human health. His work on paraoxonases aims to elucidate their role in modulating neurotoxicity and susceptibility to diseases, particularly in the context of neurotoxic exposures and genetic factors.

ConclusionĀ 

In conclusion, Clement E. Furlong, PhD, exemplifies the qualities of an outstanding researcher suitable for the Best Researcher Award. His extensive education, significant contributions to the field of biochemistry and molecular biology, and dedication to mentoring emerging scientists position him as a leader in his field. By addressing opportunities for public engagement and interdisciplinary collaboration, Dr. Furlong can enhance the impact of his already impressive body of work, making him an exemplary candidate for this esteemed award.

šŸ“š PublilcationĀ 

  • PON1 Status in Relation to Gulf War Illness: Evidence of Geneā€“Exposure Interactions from a Multisite Caseā€“Control Study of 1990ā€“1991 Gulf War Veterans
    • Year: 2024
    • Journal: International Journal of Environmental Research and Public Health
  • Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain
    • Year: 2022
    • Journal: BMC Neuroscience
  • Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brain
    • Year: 2021
    • Journal: Neurotoxicology and Teratology
  • Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates
    • Year: 2021
    • Journal: Current Protocols

Joanna Jazowiecka-Rakus | oncolytic virotherapy | Best Researcher Award

Posted on by sciencefather

Joanna Jazowiecka-Rakus | oncolytic virotherapy | Best Researcher AwardšŸ†


Assistant Professor atĀ Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland
šŸŽ“

Joanna Jazowiecka-Rakus is an Assistant Professor with a strong focus on advancing cancer research through innovative oncolytic therapies. Her work at the Maria Skłodowska Memorial National Institute of Oncology in Gliwice, Poland, positions her as a leading expert in experimental cancer treatments. Dr. Jazowiecka-Rakusā€™s pioneering research in oncolytic virotherapy and nanocarrier drug delivery aims to address complex cancers like pancreatic adenocarcinoma, glioma, and melanoma. With a reputation for pushing boundaries in cancer treatment, she continues to make strides in developing therapies that offer new hope for patients with challenging diagnoses.

Professional ProfileĀ 

šŸŽ“ Education

Dr. Jazowiecka-Rakus holds a Master of Science in Biology from the Faculty of Biology, University of Silesia, Katowice, Poland (2001), followed by a Ph.D. in Medical Biology from the National Institute of Oncology, Warsaw, Poland (2007). In recognition of her exceptional contributions to cancer research, she earned a D.Sc. (habilitation) in Medical Sciences from the same institution. Her academic path reflects her dedication to enhancing cancer treatment through rigorous scientific training and specialization.

šŸ¢ Work Experience

Throughout her career, Dr. Jazowiecka-Rakus has held esteemed research positions, including her current role as an Assistant Professor at the National Institute of Oncology. Her work has been instrumental in projects funded by prestigious institutions like the International Center for Genetic Engineering and Biotechnology and the National Science Center of Poland. Notably, her research covers a wide spectrum of experimental cancer therapies, including the use of myxoma viruses and mesenchymal stem cells to treat melanoma, ovarian cancer, and glioma. She has also forged valuable collaborations with global institutions, such as the Biodesign Institute at the University of Arizona, Tempe, USA.

šŸ§¬ Skills

Dr. Jazowiecka-Rakus brings a wealth of expertise in cancer treatment, highlighted by her skills in oncolytic virotherapy, cancer immunotherapy, and advanced drug delivery systems. Her work with oncolytic virotherapy focuses on developing viral therapies that specifically target and destroy cancer cells, offering a promising alternative to traditional cancer treatments. In cancer immunotherapy, she integrates immune-enhancing agents to create therapies for advanced cancers. Her pioneering methods for stem cell-based drug delivery use mesenchymal stem cells as carriers for oncolytic viruses, targeting tumor cells more effectively. Additionally, she has developed nanocarrier drug formulations that improve the delivery and efficacy of drugs in cancer treatment.

Awards and Honors šŸ†

Dr. Jazowiecka-Rakusā€™s dedication to cancer research has earned her numerous accolades. Between 2017 and 2020, she was awarded a research grant by the International Center for Genetic Engineering and Biotechnology to study oncolytic melanoma therapy, underlining her impact in this vital area. Her scholarly contributions include 18 articles published in high-impact journals indexed in Web of Science and Scopus, reflecting her influence and recognition within the cancer research community. Her works have accumulated a citation index of over 431, showcasing the significant reach and impact of her research.

šŸŒ Memberships

Active in professional societies, Dr. Jazowiecka-Rakus is an auditor for the Association for the Support of Cancer Research in Gliwice, Poland, where she contributes to promoting research integrity and supporting advancements in cancer studies. She is also a member of the Polish Radiation Research Society based in Warsaw, where she engages with other professionals dedicated to improving cancer treatment and sharing knowledge within the field.

šŸ“š Teaching Experience

As an Assistant Professor, Dr. Jazowiecka-Rakus is committed to educating and mentoring the next generation of cancer researchers at the National Institute of Oncology. Her teaching covers essential aspects of oncology and medical biology, with a particular focus on innovative treatment strategies in cancer research. Through her courses and mentoring, she guides students in understanding the complexities of cancer treatment, encouraging them to pursue research that makes a real-world impact.

šŸ”¬ Research Focus

Dr. Jazowiecka-Rakusā€™s research centers on developing experimental therapies for aggressive cancers. Her work includes the creation of oncolytic myxoma virus constructs, which use mesenchymal stem cells as carriers to deliver viral therapies specifically targeting cancers such as pancreatic adenocarcinoma and glioma. She has developed advanced blood-brain barrier crossing techniques to treat glioma through intra-arterial delivery, offering a new method to target brain tumors effectively. Additionally, her research on 3D models for cancer uses spheroid and organoid models to test therapies for disseminated ovarian cancer, pushing the boundaries of cancer treatment with innovative laboratory models that mimic real-world conditions. Dr. Jazowiecka-Rakusā€™s interdisciplinary approach highlights her dedication to advancing the field of cancer therapy and improving patient outcomes.

ConclusionĀ 

In conclusion, Dr. Joanna Jazowiecka-Rakus exemplifies the qualities of an outstanding researcher through her innovative projects, significant contributions to cancer research, and a strong academic foundation. Her ongoing work and potential for future advancements make her a deserving candidate for the Best Researcher Award. Enhancing her publication record and pursuing patent opportunities would further solidify her standing as a leader in the field.

šŸ“š PublilcationĀ 

  • Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Bloodā€“Brain Barrier and Treat Murine Glioma
  • Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
  • Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma
  • Removal of Heavy Metal Ions from Wastewaters: An Application of Sodium Trithiocarbonate and Wastewater Toxicity Assessment
  • COVID-19 Autopsies: A Case Series from Poland
  • Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
  • Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses

 

Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher Award

Posted on by sciencefather

Dr. Joanna Bartkowiak-Wieczorek | Pharmacology | Best Researcher AwardĀ šŸ†

Poznan University of Medical Sciences, PolandšŸŽ“

Dr.Joanna Bartkowiak-Wieczorek is an accomplished researcher and Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, specializing in pharmacology and pharmacogenetics. With a strong focus on cannabinoids and their potential medical applications, particularly in oncology and personalized medicine, she has contributed significantly to understanding how genetic factors influence drug response. Joanna’s work has been recognized with the Best Researcher Award, reflecting her dedication to advancing pharmacological research and education. She is committed to bridging the gap between scientific inquiry and clinical practice, enhancing the safety and efficacy of pharmacotherapy for diverse patient populations.

 

Professional ProfileĀ 

 

šŸŽ“ Education

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.

šŸ¢ Work Experience

Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.

 

Awards and Honors šŸ†

Joanna has participated in various research projects funded by the National Science Centre, focusing on pharmacogenetics and the development of technologies for cannabinoid extraction for cancer treatment. Her contributions to scientific knowledge have been recognized through numerous publications in reputable journals, reflecting her commitment to advancing research in her field.

šŸ”¬ Research Focus

Joanna’s research primarily explores cannabinoids, their pharmacological properties, and applications in oncology and personalized medicine. She has conducted significant studies on the influence of individual genes on drug responses and has a strong background in pharmacogenetics, drug interactions, and the therapeutic potential of plant-based compounds.

ConclusionĀ 

Joanna’s qualifications and achievements position her as a leading figure in her field, making her a suitable candidate for the Best Researcher Award. By addressing the identified areas for improvement, she could further enhance her research impact and continue to contribute to advancements in pharmacology and personalized medicine.

šŸ“š PublilcationĀ 

  1. Bartkowiak-Wieczorek, J., et al. (2024). Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat. Biomolecules. DOI: 10.3390/biom14091065
  2. Bartkowiak-Wieczorek, J., et al. (2024). Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi: A Promising Candidate for Cancer, Alzheimerā€™s Disease, and Obesity Treatment. Nutrients. DOI: 10.3390/nu16152509
  3. Bartkowiak-Wieczorek, J., et al. (2024). The Dual Faces of Oestrogen: The Impact of Exogenous Oestrogen on Physiological and Pathophysiological Functions of Tissues and Organs. International Journal of Molecular Sciences. DOI: 10.3390/ijms25158167
  4. Bartkowiak-Wieczorek, J., et al. (2024). Natural Products and Health. Nutrients. DOI: 10.3390/nu16030415
  5. Bartkowiak-Wieczorek, J. (2023). A Critical Look at New Possibilities of Therapeutic Use of Statins: A Summary of Current Knowledge. Farmacja Polska. DOI: 10.32383/farmpol/174070
  6. Bartkowiak-Wieczorek, J., et al. (2023). THC-Reduced Cannabis sativa L.ā€”How Does the Solvent Determine the Bioavailability of Cannabinoids Given Orally?. Nutrients. DOI: 10.3390/nu15122646
  7. Bartkowiak-Wieczorek, J., et al. (2022). The Dark Side of Iron: The Relationship Between Iron, Inflammation, and Gut Microbiota in Diseases Associated with Iron Deficiency Anaemia. Nutrients. DOI: 10.3390/nu14173478
  8. Bartkowiak-Wieczorek, J. (2022). Polygraph Analyses: Technical and Practical Background. Journal of Medical Science. DOI: 10.20883/medical.e590
  9. Bartkowiak-Wieczorek, J., et al. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells. DOI: 10.3390/cells10113164
  10. Bartkowiak-Wieczorek, J., et al. (2020). Relationship Between Adipocytokines and Angiotensin-Converting Enzyme Gene Polymorphism in Lean Women with and without Polycystic Ovary Syndrome. Gynecological Endocrinology. DOI: 10.1080/09513590.2019.1695248
  11. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Different Water Extracts from Platycodon grandiflorum on Pathogenesis of Chronic Bronchitis in Rats. Molecules. DOI: 10.3390/molecules25215020
  12. Bartkowiak-Wieczorek, J., et al. (2020). Effect of Genetic Variations for Interleukin-10 on Efficacy of Immunosuppressive Therapy in Kidney Transplant Patients. International Immunopharmacology. DOI: 10.1016/j.intimp.2020.107059
  13. Bartkowiak-Wieczorek, J. (2020). The MDR1/ABCB1 Gene Polymorphism in Colorectal Cancer. Archives of Medical Science. DOI: 10.5114/aoms.2017.70329
  14. Bartkowiak-Wieczorek, J., et al. (2019). Effect of MDR1 and CYP3A41B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients*. Annals of Transplantation. DOI: 10.12659/AOT.914683
  15. Bartkowiak-Wieczorek, J. (2018). Demographic Factors Determining Folic Acid Supplementation in Pregnant and Childbearing-Age Women. Ginekologia Polska. DOI: 10.5603/GP.a2018.0036
  16. Bartkowiak-Wieczorek, J. (2018). Effect of Interleukin-6 Polymorphism on Renal Allograft Function and Immunosuppressive Therapy Efficacy. Farmacia. DOI: 10.31925/farmacia.2018.5.8
  17. Bartkowiak-Wieczorek, J., et al. (2018). Importance of New Generation Sequencing HLA Typing in Renal Transplantationā€”Preliminary Report. Transplantation Proceedings. DOI: 10.1016/j.transproceed.2018.05.005
  18. Bartkowiak-Wieczorek, J., et al. (2017). Effect of Salvia miltiorrhiza Root Extract on Brain Acetylcholinesterase, Butyrylcholinesterase Activities, mRNA Levels, and Memory in Rats. Physiology and Behavior. DOI: 10.1016/j.physbeh.2017.02.019
  19. Bartkowiak-Wieczorek, J. (2017). Role of the ITLN1 Gene Allelic Variant in Patients with Diabetic Foot. Polish Archives of Internal Medicine. DOI: 10.20452/pamw.4008
  20. Bartkowiak-Wieczorek, J., et al. (2017). Polymorphic Variants of Collagen 1A2 Gene in Osteopenia and Osteoporosis Development in Postmenopausal Women. Ginekologia Polska. DOI: 10.5603/GP.A2017.0077
  21. Bartkowiak-Wieczorek, J., et al. (2016). Analysis of Aldosterone Synthase and Atrial Natriuretic Peptide Gene Polymorphisms in Women with Preeclampsia. European Journal of Obstetrics and Gynecology and Reproductive Biology. DOI: 10.1016/j.ejogrb.2015.11.012
  22. Bartkowiak-Wieczorek, J. (2016). Association Between ACE Gene Polymorphism and Metabolic Disturbances in PCOS Women. Molecular Medicine Reports. DOI: 10.3892/mmr.2016.5910
  23. Bartkowiak-Wieczorek, J., et al. (2016). Influence of Melissa officinalis Leaf Extract on Long-Term Memory in Scopolamine Animal Model. Evidence-Based Complementary and Alternative Medicine. DOI: 10.1155/2016/9729818
  24. Bartkowiak-Wieczorek, J. (2016). Association Between Metabolic Syndrome Development in PCOS Patients and MTHFR Gene Polymorphism. Ginekologia Polska. DOI: 10.17772/gp/61751
  25. Bartkowiak-Wieczorek, J., et al. (2016). Antinociceptive and Anti-Inflammatory Effects of Oleanolic Acid and Aspirin Conjugate. Frontiers in Pharmacology. DOI: 10.3389/fphar.2016.00202
  26. Bartkowiak-Wieczorek, J. (2016). Importance of MDR1 Gene Polymorphisms in Colorectal Cancer Etiology. Przegląd Gastroenterologiczny. DOI: 10.5114/pg.2015.51185
  27. Bartkowiak-Wieczorek, J., et al. (2016). Influence of TNF-Ī± Polymorphism on Immunosuppressive Therapy Efficacy in Kidney Transplant Patients. Journal of Physiology and Pharmacology.
  28. Bartkowiak-Wieczorek, J. (2016). Significance of Genetic Polymorphisms in the RANKL/RANK/OPG Signaling Pathway in Postmenopausal Osteoporosis. Ginekologia Polska. DOI: 10.5603/GP.2016.0014
  29. Bartkowiak-Wieczorek, J., et al. (2015). Analysis of ADIPOQ Gene Polymorphisms in Women with Excessive Weight Gain During Pregnancy. Ginekologia Polska. DOI: 10.17772/gp/2421
  30. Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of Anti-Inflammatory and Analgesic Activities of Extracts from Chelidonium majus L. Herb. Central European Journal of Immunology. DOI: 10.5114/ceji.2015.54607
  31. Bartkowiak-Wieczorek, J. (2015). *Gender-Specific Implications for Pharmacology in Women of Child